Application Of Traditional Chinese Medicine In The Field Of Prevention And Treatment Of Influenza A
DOI:
https://doi.org/10.62051/v9kaej46Keywords:
Traditional Chinese Medicine (TCM); H1N1 influenza; antiviral activity; clinical efficacy; integrated medicine.Abstract
Traditional Chinese Medicine (TCM) has demonstrated multifaceted therapeutic potential in the prevention and treatment of H1N1 influenza (swine flu), leveraging its antiviral, immunomodulatory, and anti-inflammatory properties. Studies highlight the efficacy of classic formulations such as Yinqiao San (Honeysuckle and Forsythia Powder) and Yupingfeng San (Jade Screen Powder) in alleviating symptoms (e.g., fever, cough), shortening disease duration, and reducing complications. Active compounds like chlorogenic acid (from honeysuckle) and epigoitrin (from Isatis root) inhibit viral replication by targeting neuraminidase and PB2 proteins, while enhancing host immunity through interferon induction. Clinical trials suggest that integrating TCM with conventional antivirals (e.g., oseltamivir) improves recovery rates and mitigates post-infection fatigue. However, challenges persist, including insufficient high-quality randomized controlled trials (RCTs), variability in herbal quality control, and undefined mechanisms of multi-component synergism. Future directions emphasize large-scale RCTs, AI-driven component screening, and global guideline development to standardize TCM applications. This integrative approach may redefine pandemic preparedness by harmonizing TCM’s holistic principles with evidence-based medicine.
Downloads
References
[1] CHI Xu-ying, FU Yong-mei, CUI Yue-xin, ZHANG Shu, DENG Hong. Correlation between chemical constituents of Isatidis Radix and bioactivity of neuraminidase on anti-influenza virus[J]. Chinese Traditional and Herbal Drugs, 2016, 47(22): 3982-3989.
[2] Li M, Wang Y, Jin J, Dou J, Guo Q, Ke X, Zhou C, Guo M. Inhibitory activity of honeysuckle extracts against influenza A virus in vitro and in vivo[J]. Virologica Sinica, 2021, 36(3): 490-500.
[3] XIONG Mingbiao, CAO Hui, YANG Deqian. Meta analysis of the efficacy and safety of Lianhua Qingwen capsule versus oseltamivir in the treatment of influenza[J]. Journal of Pharmaceutical Practice and Service, 2021, 39(5): 454-459.
[4] Zhang Q, Yang C, Ma S, Guo S, Hu X, Zhou Z, Liu Y, Zhang X, Jiang R, Zhang Z, Wen L, Qing S. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury[J]. Journal of Ethnopharmacology, 2023, 313: 116615.
[5] Li ZT, Li L, Chen TT, Li CY, Wang DQ, Yang ZF, Zhong NS. Efficacy and safety of Ban-Lan-Gen granules in the treatment of seasonal influenza: study protocol for a randomized controlled trial[J]. Trials, 2015, 16: 126.
[6] Zhou Z, Li X, Liu J, et al. Honeysuckle-encoded atypical microRNA2911 directly targets influenza A viruses[J]. Cell Research, 2015, 25: 39–49.
[7] Yuan C, Guan Y. Efficacy and safety of Lianhua Qingwen as an adjuvant treatment for influenza in Chinese patients: A meta-analysis[J]. Medicine (Baltimore), 2024, 103(3): e36986.
[8] Han JN. Treatment of influenza: Chinese medicine vs. western medicine[J]. Journal of Thoracic Disease, 2011, 4: 10-11.
[9] Liu DF, Liu YL, Chen H, Zeng YL, Wen XM, et al. Evaluation on the curative effect and safety of Chinese traditional medicine in treatment of mild A/H1N1 influenza in Sichuan area[J]. Modern Preventive Medicine, 2011, 38: 338–343. (In Chinese)
[10] Chen W, Lim CED, Kang HJ, Liu J. Chinese herbal medicines for the treatment of type A H1N1 influenza: a systematic review of randomized controlled trials[J]. PLoS ONE, 2011, 6(12): e28093.
[11] Gottlieb S. Chinese herb may cause cancer (news)[J]. BMJ, 2000, 320: 1623.
[12] Shizaki T, Sasaki F, Ameshima S, Shiozaki K, Takahashi H, et al. Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis[J]. European Respiratory Journal, 1996, 9: 2691–2696.
[13] Melchart D, Linde K, Weidenhammer W, Hager S, Shaw D, et al. Liver enzyme elevations in patients treated with traditional Chinese medicine[J]. JAMA, 1999, 282: 28–29.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Transactions on Materials, Biotechnology and Life Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
